PCa is usually asymptomatic at the early stage and mostly diagnosed through the blood test of prostate-specific antigen (PSA), a biomarker widely used for over 20 years (2), combined with magnetic resonance imaging (MRI) and digital rectal examination. The gene discussed is KLK3; the disease is posterior cortical atrophy.